Cargando…
A hierarchical approach to combine histological grade and immunohistochemical factors to identify high-risk luminal breast cancers
BACKGROUND: The luminal subtype accounts for ~70% of newly diagnosed breast cancer patients. Although it has a better prognosis, approximately 30% of them develop a late relapse. Identifying those patients is of interest to improve treatment decisions. METHODS: A retrospective observational, single-...
Autores principales: | da Luz, Felipe Andrés Cordero, da Costa Marinho, Eduarda, Nascimento, Camila Piqui, de Andrade Marques, Lara, Delfino, Patrícia Ferreira Ribeiro, Antonioli, Rafael Mathias, de Araújo, Rogério Agenor, Silva, Marcelo José Barbosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300407/ https://www.ncbi.nlm.nih.gov/pubmed/35919235 http://dx.doi.org/10.3332/ecancer.2022.1382 |
Ejemplares similares
-
The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
por: da Luz, Felipe Andrés Cordero, et al.
Publicado: (2022) -
Prognosis value of lymphovascular invasion in patients with invasive ductal breast carcinoma according to lymph node metastasis status
por: da Luz, Felipe Andrés Cordero, et al.
Publicado: (2022) -
Survival differences between women and men in the non-reproductive cancers: Results from a matched analysis of the surveillance, epidemiology, and end-results program
por: da Luz, Felipe Andrés Cordero, et al.
Publicado: (2023) -
Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program
por: da Luz, Felipe Andrés Cordero, et al.
Publicado: (2023) -
Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker
por: de Araújo, Rogério Agenor, et al.
Publicado: (2022)